Search research articles
Contact Us
Filters
Showing results (91-100 of 154) with videos related to
Page
of 16
Sort By:
European Urology Oncology
|
August 2, 2024
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy: A Systematic Review and Meta-analysis of Prospective Studies
Fabio Zattoni, Pawel Rajwa, Marcin Miszczyk, et al.
Prostate Cancer and Prostatic Diseases
|
October 12, 2023
Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program
Giacomo Novara, Fabio Zattoni, Giovanni Zecchini, et al.
European Urology Open Science
|
April 28, 2025
Personalised Prostate Cancer Diagnosis: Evaluating Biomarker-based Approaches to Reduce Unnecessary Magnetic Resonance Imaging and Biopsy Procedures
Timo F W Soeterik, Xiaobo Wu, Roderick C N Van den Bergh, et al.
European Urology Open Science
|
March 21, 2025
Perioperative, Oncological, and Functional Outcomes of New Multiport Robotic Platforms in Urology: A Systematic Review and Meta-analysis
Giuseppe Reitano, Arianna Tumminello, Umar Ghaffar, et al.
European Urology Oncology
|
February 22, 2023
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review
Francesco Mattana, Lorenzo Muraglia, Pawel Rajwa, et al.
Central European Journal of Urology
|
November 3, 2021
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional study
Fabio Zattoni, Giancarlo Marra, Alexander Kretschmer, et al.
Diagnostics (Basel, Switzerland)
|
May 13, 2026
Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy
Fabio Zattoni, Andrea Mari, Ugo Giovanni Falagario, et al.
Clinical Genitourinary Cancer
|
November 28, 2024
Safety and Efficacy of <sup>177</sup>Lu-PSMA Therapy Following <sup>223</sup>Radium Treatment: A Retrospective Multinational Real-World Analysis
Giulia Giannini, Mona Kafka, Hannes Neuwirt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 6, 2024
A Prospective Randomized Multicenter Study on the Impact of [<sup>18</sup>F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer
Laura Evangelista, Fabio Zattoni, Marta Burei, et al.
Therapeutic Advances in Medical Oncology
|
March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
Isabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 154) with videos related to
Sort By:
Page
of 16
European Urology Oncology
|
August 2, 2024
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy: A Systematic Review and Meta-analysis of Prospective Studies
Fabio Zattoni, Pawel Rajwa, Marcin Miszczyk, et al.
Prostate Cancer and Prostatic Diseases
|
October 12, 2023
Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program
Giacomo Novara, Fabio Zattoni, Giovanni Zecchini, et al.
European Urology Open Science
|
April 28, 2025
Personalised Prostate Cancer Diagnosis: Evaluating Biomarker-based Approaches to Reduce Unnecessary Magnetic Resonance Imaging and Biopsy Procedures
Timo F W Soeterik, Xiaobo Wu, Roderick C N Van den Bergh, et al.
European Urology Open Science
|
March 21, 2025
Perioperative, Oncological, and Functional Outcomes of New Multiport Robotic Platforms in Urology: A Systematic Review and Meta-analysis
Giuseppe Reitano, Arianna Tumminello, Umar Ghaffar, et al.
European Urology Oncology
|
February 22, 2023
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review
Francesco Mattana, Lorenzo Muraglia, Pawel Rajwa, et al.
Central European Journal of Urology
|
November 3, 2021
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional study
Fabio Zattoni, Giancarlo Marra, Alexander Kretschmer, et al.
Diagnostics (Basel, Switzerland)
|
May 13, 2026
Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy
Fabio Zattoni, Andrea Mari, Ugo Giovanni Falagario, et al.
Clinical Genitourinary Cancer
|
November 28, 2024
Safety and Efficacy of <sup>177</sup>Lu-PSMA Therapy Following <sup>223</sup>Radium Treatment: A Retrospective Multinational Real-World Analysis
Giulia Giannini, Mona Kafka, Hannes Neuwirt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 6, 2024
A Prospective Randomized Multicenter Study on the Impact of [<sup>18</sup>F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer
Laura Evangelista, Fabio Zattoni, Marta Burei, et al.
Therapeutic Advances in Medical Oncology
|
March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
Isabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
Page
of 16